The research firm downgraded the biotechnology stock to sell from neutral.
Brief · CNBC Top News
Moderna is now overvalued after cancer vaccine-led stock surge, Rothschild & Co. says
Medium impact Health Care
Free market news · Delayed data
Native English edition
findailys
Markets, sectors, and the stories moving them